Posted on May 5, 2025
Today, Little Hercules Foundation, joined by 57 patient advocacy organizations serving rare disease patients and their families, sent this letter to Independence Blue Cross Blue Shield (IBX) regarding their policy excluding coverage of all treatments approved via FDA's accelerated approval pathway. Thank you to our fellow rare disease advocates, including many DMD organizations, that joined our efforts to change this dangerous policy. Approved is approved.
Posted on May 8, 2023
Hear directly from the SRP-9001 PI's expert views on treatment effect in their patients.
Posted on June 26, 2018
Read our latest blog post by one of our Personalized Access Team (PACT) Managers, Amy Aikins, whose long family history with Duchenne inspires her to help others, including her son, live their best lives by helping them get what they need.
Little Hercules Foundation relies on the generosity of individuals around the world, like you, who believe in our mission and in the power to make a difference in the lives of those diagnosed with — and families fighting against — Duchenne muscular dystrophy.